Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil-derived oxygen radical release modulation refers to the regulation of the production and release of reactive oxygen species (ROS), also known as oxygen radicals, by neutrophils. These ROS, produced primarily through the NADPH oxidase (NOX2) complex, are crucial for microbial killing and immunomodulation. However, dysregulation of ROS production can contribute to tissue damage and inflammatory diseases. Modulation involves targeting the NOX2 complex, downstream enzymes like superoxide dismutase (SOD) and myeloperoxidase (MPO), or directly scavenging ROS. Agents include activators (e.g., phorbol esters) and inhibitors/scavengers (e.g., N-acetylcysteine, taurine). Aberrant modulation is implicated in various diseases, highlighting the need for careful therapeutic targeting.
Modulation of NADPH oxidase (NOX2) activity, regulation of superoxide dismutase (SOD) and myeloperoxidase (MPO) activity, scavenging of reactive oxygen species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil-derived oxygen radical release modulation.